Hansen, Morten Lock
Rigshospitalet
10 papers on CoChatORCID 0000-0001-7996-5005
Most cited papers
- Verified
Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation
Hansen, M. L., Sørensen, R., Clausen, M. T., Fog-Petersen, M. L., Raunsø, J., Gadsbøll, N., Gislason, G. H., Folke, F., Andersen, S. S., Schramm, T. K., et al. (2010) · Archives of Internal Medicine
Atrial Fibrillation Management and OutcomesAntiplatelet Therapy and Cardiovascular Diseases
Cited by 855
- Verified
Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a ‘real world’ nationwide cohort study
Lip, G., Lindhardsen, J., Lane, D., Ahlehoff, O., Hansen, M., Raunsø, J., Tolstrup, J., Hansen, P., Gislason, G., Torp-Pedersen, C., et al. (2011) · Thrombosis and Haemostasis
Atrial Fibrillation Management and OutcomesVenous Thromboembolism Diagnosis and Management
Cited by 428
- Verified
Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study
Schramm, T. K., Gislason, G. H., Vaag, A., Rasmussen, J. N., Folke, F., Hansen, M. L., Fosbøl, E. L., Køber, L., Norgaard, M. L., Madsen, M., et al. (2011) · European Heart Journal
Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 418
- Verified
Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and Coronary Intervention: A Nationwide Cohort Study
Lamberts, M., Olesen, J. B., Ruwald, M. H., Hansen, C. M., Karasoy, D., Kristensen, S. L., Køber, L., Torp-Pedersen, C., Gislason, G. H., & Hansen, M. L. (2012) · Circulation
Atrial Fibrillation Management and OutcomesAntiplatelet Therapy and Cardiovascular Diseases
Cited by 413
- Verified
The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study
Selmer, C., Olesen, J. B., Hansen, M. L., Lindhardsen, J., Olsen, A.-M. S., Madsen, J. C., Faber, J., Hansen, P. R., Pedersen, O. D., Torp-Pedersen, C., et al. (2012) · BMJ
Thyroid Disorders and TreatmentsAtrial Fibrillation Management and Outcomes
Cited by 323
- Verified
Subclinical and Overt Thyroid Dysfunction and Risk of All-Cause Mortality and Cardiovascular Events: A Large Population Study
Selmer, C., Olesen, J. B., Hansen, M. L., von Kappelgaard, L. M., Madsen, J. C., Hansen, P. R., Pedersen, O. D., Faber, J., Torp-Pedersen, C., & Gislason, G. H. (2014) · The Journal of Clinical Endocrinology & Metabolism
Thyroid Disorders and TreatmentsThyroid and Parathyroid Surgery
Cited by 288
- Verified
Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study
Staerk, L., Lip, G. Y. H., Olesen, J. B., Fosbøl, E. L., Pallisgaard, J. L., Bonde, A. N., Gundlund, A., Lindhardt, T. B., Hansen, M. L., Torp-Pedersen, C., et al. (2015) · BMJ
Atrial Fibrillation Management and OutcomesGastrointestinal Bleeding Diagnosis and Treatment
Cited by 146
- Verified
Oral anticoagulation therapy after radiofrequency ablation of atrial fibrillation and the risk of thromboembolism and serious bleeding: long-term follow-up in nationwide cohort of Denmark
Karasoy, D., Gislason, G. H., Hansen, J., Johannessen, A., Køber, L., Hvidtfeldt, M., Özcan, C., Torp-Pedersen, C., & Hansen, M. L. (2015) · European Heart Journal
Atrial Fibrillation Management and OutcomesVenous Thromboembolism Diagnosis and Management
Cited by 132
- Verified
Accuracy of the ICD-10 discharge diagnosis for syncope
Ruwald, M. H., Hansen, M. L., Lamberts, M., Kristensen, S. L., Wissenberg, M., Olsen, A.-M. S., Christensen, S. B., Vinther, M., Kober, L., Torp-Pedersen, C., et al. (2013) · Europace
Medical Coding and Health InformationCardiovascular Syncope and Autonomic Disorders
Cited by 79
- Verified
Comparison of Incidence, Predictors, and the Impact of Co-Morbidity and Polypharmacy on the Risk of Recurrent Syncope in Patients <85 Versus ≥85 Years of Age
Ruwald, M. H., Hansen, M. L., Lamberts, M., Hansen, C. M., Numé, A.-K., Vinther, M., Køber, L., Torp-Pedersen, C., Hansen, J., & Gislason, G. H. (2013) · The American Journal of Cardiology
Cardiovascular Syncope and Autonomic DisordersPharmaceutical Practices and Patient Outcomes
Cited by 59
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free